| 发明名称 |
Use of the phytocannabinoid cannabidivarin (CBDV) in the treatment of epilepsy |
| 摘要 |
<p>This invention relates to the use of the phytocannabinoid cannabidivarin (CBDV) and combinations of the phytocannabinoid CBDV with tetrahydrocannabivarin (THCV) and cannabidiol (CBD) in the treatment of epilepsy. The invention further relates to the use of the phytocannabinoid CBDV in combination with standard anti-epileptic drugs (SAEDs). Preferably the SAED is one of ethosuximide, valproate or phenobarbital.</p> |
| 申请公布号 |
AU2011234225(A1) |
申请公布日期 |
2012.11.08 |
| 申请号 |
AU20110234225 |
申请日期 |
2011.03.30 |
| 申请人 |
GW PHARMA LIMITED;OTSUKA PHARMACEUTICAL CO., LIMITED |
发明人 |
WHALLEY, BENJAMIN;WILLIAMS, CLAIRE;STEPHENS, GARY;FUTAMURA, TAKASHI |
| 分类号 |
A61K31/05;A61K31/19;A61K31/352;A61K31/40;A61K36/185;A61K45/06;A61P25/08 |
主分类号 |
A61K31/05 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
